Northern Trust Corp Athenex, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.41 - $0.91 $234,645 - $520,798	-572,306 Reduced 80.95%	134,722 $55,000
Q1 2022 May 13, 2022	SELL	$0.79 - $1.59 $43,773 - $88,101	-55,410 Reduced 7.27%	707,028 $587,000
Q4 2021 Feb 08, 2022	SELL	$1.36 - $2.94 $56,396 - $121,915	-41,468 Reduced 5.16%	762,438 $1.04 Million
Q3 2021 Nov 15, 2021	SELL	$2.97 - $4.84 $157,282 - $256,311	-52,957 Reduced 6.18%	803,906 $2.42 Million
Q2 2021 Aug 13, 2021	BUY	$3.71 - $5.13 $324,584 - $448,818	87,489 Added 11.37%	856,863 $3.96 Million
Q1 2021 May 12, 2021	SELL	$4.08 - $14.75 $185,162 - $669,399	-45,383 Reduced 5.57%	769,374 $3.31 Million
Q4 2020 Feb 11, 2021	BUY	$11.06 - $14.01 $889,157 - $1.13 Million	80,394 Added 10.95%	814,757 $9.01 Million
Q3 2020 Nov 16, 2020	SELL	$10.26 - $14.55 $628,065 - $890,678	-61,215 Reduced 7.69%	734,363 $8.89 Million
Q2 2020 Aug 14, 2020	BUY	$7.11 - $13.76 $77,683 - $150,341	10,926 Added 1.39%	795,578 $10.9 Million
Q1 2020 May 14, 2020	BUY	$5.71 - $15.85 $21,218 - $58,898	3,716 Added 0.48%	784,652 $6.07 Million
Q4 2019 Feb 14, 2020	SELL	$9.6 - $17.75 $188,016 - $347,633	-19,585 Reduced 2.45%	780,936 $11.9 Million
Q3 2019 Nov 13, 2019	BUY	$12.16 - $21.0 $2.68 Million - $4.63 Million	220,509 Added 38.02%	800,521 $9.74 Million
Q2 2019 Aug 13, 2019	BUY	$9.44 - $19.8 $418,343 - $877,456	44,316 Added 8.27%	580,012 $11.5 Million
Q1 2019 May 13, 2019	SELL	$11.11 - $13.49 $95,012 - $115,366	-8,552 Reduced 1.57%	535,696 $6.56 Million
Q4 2018 Feb 12, 2019	SELL	$10.24 - $15.49 $96,368 - $145,776	-9,411 Reduced 1.7%	544,248 $6.91 Million
Q3 2018 Nov 14, 2018	BUY	$15.53 - $19.97 $655,101 - $842,394	42,183 Added 8.25%	553,659 $8.6 Million
Q2 2018 Sep 18, 2018	BUY	$15.88 - $19.5 $389,361 - $478,120	24,519 Added 5.04%	511,476 $9.55 Million
Q2 2018 Aug 14, 2018	BUY	$15.88 - $19.5 $5.41 Million - $6.64 Million	340,721 Added 232.99%	486,957 $9.09 Million
Q1 2018 May 09, 2018	BUY	$13.53 - $17.47 $964,513 - $1.25 Million	71,287 Added 95.11%	146,236 $2.49 Million
Q4 2017 Feb 14, 2018	BUY	$14.41 - $19.15 $65,003 - $86,385	4,511 Added 6.4%	74,949 $1.19 Million
Q3 2017 Nov 13, 2017	BUY	$13.5 - $19.51 $950,913 - $1.37 Million	70,438	70,438 $1.23 Million

Others Institutions Holding ATNX

# of Institutions

Shares Held

1.46M

Call Options Held

Put Options Held

Empery Asset Management, LP New York, NY

1.45M
Shares

$14,521
2.33% of portfolio
Eaton Vance Management Boston, MA

12K
Shares

$120
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Athenex, Inc.

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

More about ATNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account